COMPASS PATHWAYS PLC (CMPS) Fundamental Analysis & Valuation
NASDAQ:CMPS • US20451W1018
Current stock price
6.39 USD
-0.24 (-3.62%)
At close:
6.4 USD
+0.01 (+0.16%)
After Hours:
This CMPS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CMPS Profitability Analysis
1.1 Basic Checks
- In the past year CMPS has reported negative net income.
- CMPS had a negative operating cash flow in the past year.
- CMPS had negative earnings in each of the past 5 years.
- In the past 5 years CMPS always reported negative operating cash flow.
1.2 Ratios
- CMPS's Return On Assets of -92.84% is on the low side compared to the rest of the industry. CMPS is outperformed by 73.60% of its industry peers.
- CMPS has a Return On Equity of -631.31%. This is in the lower half of the industry: CMPS underperforms 78.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -92.84% | ||
| ROE | -631.31% | ||
| ROIC | N/A |
ROA(3y)-53.97%
ROA(5y)-43.08%
ROE(3y)-67.74%
ROE(5y)-51.83%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for CMPS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. CMPS Health Analysis
2.1 Basic Checks
- Compared to 1 year ago, CMPS has more shares outstanding
- Compared to 5 years ago, CMPS has more shares outstanding
- CMPS has a worse debt/assets ratio than last year.
2.2 Solvency
- CMPS has an Altman-Z score of -4.42. This is a bad value and indicates that CMPS is not financially healthy and even has some risk of bankruptcy.
- CMPS's Altman-Z score of -4.42 is on the low side compared to the rest of the industry. CMPS is outperformed by 60.69% of its industry peers.
- A Debt/Equity ratio of 0.49 indicates that CMPS is not too dependend on debt financing.
- CMPS has a Debt to Equity ratio of 0.49. This is in the lower half of the industry: CMPS underperforms 70.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.42 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- CMPS has a Current Ratio of 1.23. This is a normal value and indicates that CMPS is financially healthy and should not expect problems in meeting its short term obligations.
- CMPS has a worse Current ratio (1.23) than 84.20% of its industry peers.
- CMPS has a Quick Ratio of 1.23. This is a normal value and indicates that CMPS is financially healthy and should not expect problems in meeting its short term obligations.
- CMPS's Quick ratio of 1.23 is on the low side compared to the rest of the industry. CMPS is outperformed by 83.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 1.23 |
3. CMPS Growth Analysis
3.1 Past
- CMPS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.00%.
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-157.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- CMPS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.72% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-8.79%
EPS Next 2Y12.13%
EPS Next 3Y10.02%
EPS Next 5Y9.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. CMPS Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CMPS. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CMPS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.13%
EPS Next 3Y10.02%
5. CMPS Dividend Analysis
5.1 Amount
- No dividends for CMPS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CMPS Fundamentals: All Metrics, Ratios and Statistics
6.39
-0.24 (-3.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-27 2026-02-27/amc
Earnings (Next)05-06 2026-05-06
Inst Owners52.98%
Inst Owner Change-0.85%
Ins Owners1.49%
Ins Owner Change-0.3%
Market Cap597.86M
Revenue(TTM)N/A
Net Income(TTM)-237.32M
Analysts83.53
Price Target19.84 (210.49%)
Short Float %6.44%
Short Ratio2.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-127.95%
Min EPS beat(2)-261.99%
Max EPS beat(2)6.08%
EPS beat(4)3
Avg EPS beat(4)-58.32%
Min EPS beat(4)-261.99%
Max EPS beat(4)20.36%
EPS beat(8)4
Avg EPS beat(8)-37.83%
EPS beat(12)6
Avg EPS beat(12)-28.62%
EPS beat(16)9
Avg EPS beat(16)-17.66%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.63%
PT rev (3m)14.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.4%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 15.9 | ||
| P/tB | 15.9 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.86
EYN/A
EPS(NY)-1.71
Fwd EYN/A
FCF(TTM)-1.73
FCFYN/A
OCF(TTM)-1.73
OCFYN/A
SpS0
BVpS0.4
TBVpS0.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -92.84% | ||
| ROE | -631.31% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-53.97%
ROA(5y)-43.08%
ROE(3y)-67.74%
ROE(5y)-51.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 1.23 | ||
| Altman-Z | -4.42 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)69.7%
Cap/Depr(5y)102.12%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-157.14%
EPS Next Y-8.79%
EPS Next 2Y12.13%
EPS Next 3Y10.02%
EPS Next 5Y9.72%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.37%
EBIT Next 3Y-1.87%
EBIT Next 5Y26.7%
FCF growth 1Y-40.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-40.69%
OCF growth 3YN/A
OCF growth 5YN/A
COMPASS PATHWAYS PLC / CMPS Fundamental Analysis FAQ
What is the fundamental rating for CMPS stock?
ChartMill assigns a fundamental rating of 1 / 10 to CMPS.
What is the valuation status of COMPASS PATHWAYS PLC (CMPS) stock?
ChartMill assigns a valuation rating of 0 / 10 to COMPASS PATHWAYS PLC (CMPS). This can be considered as Overvalued.
What is the profitability of CMPS stock?
COMPASS PATHWAYS PLC (CMPS) has a profitability rating of 0 / 10.
Can you provide the financial health for CMPS stock?
The financial health rating of COMPASS PATHWAYS PLC (CMPS) is 1 / 10.